• 1. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 2. Acetyl group orientation modulates the electronic ground-state asymmetry of the special pair in purple bacterial reaction centers
  P. K. Wawrzyniak,M. T. P. Beerepoot,H. J. M. de Groot,F. Buda Phys. Chem. Chem. Phys., 2011,13, 10270-10279
• 3. An antioxidative galactomannan extracted from Chinese Sesbania cannabina enhances immune activation of macrophage cells?
  Chongyang Zhu,Xiaojia Bian,Xin Jia,Ning Tang,Yongqiang Cheng Food Funct., 2020,11, 10635-10644
• 4. An analyte-triggered artificial peroxidase system based on dimanganese complex for a versatile enzyme assay?
  Suji Lee,Min Su Han Chem. Commun., 2021,57, 9450-9453
• 5. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996

3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyrrolo[1,2-a]pyrimidine

The compound 3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyrrolo[1,2-a]pyrimidine (CAS No. 2408430-26-0) is a highly specialized organic molecule that has garnered significant attention in the fields of organic synthesis and materials science. This compound is notable for its unique structural features and its potential applications in advanced chemical systems. The molecule consists of a pyrrolo[1,2-a]pyrimidine core, which is a fused bicyclic system combining pyrrole and pyrimidine moieties. This core is further substituted with a 4,4,5,5-tetramethyl-1,3,2-dioxaborolane group at the 3-position of the pyrimidine ring.

The dioxaborolane moiety is a boron-containing ring structure that imparts unique electronic and steric properties to the molecule. This group is particularly significant as it can act as a directing group in various organic transformations or as a protective group in synthesis. Recent studies have highlighted the importance of such functional groups in facilitating catalytic processes and enhancing the stability of molecular frameworks. The tetramethyl substitution pattern on the dioxaborolane ring further modulates the electronic environment and steric hindrance around the boron atom.

From a synthetic standpoint, this compound represents a milestone in the construction of complex heterocyclic systems. Its synthesis typically involves multi-step processes that combine traditional organic reactions with modern catalytic methodologies. For instance, researchers have employed transition-metal-catalyzed coupling reactions to assemble the pyrrolo[1,2-a]pyrimidine core with high precision. The incorporation of the dioxaborolane group often requires careful control over reaction conditions to ensure selective formation of the desired product.

Recent advancements in computational chemistry have provided deeper insights into the electronic structure and reactivity of this compound. Quantum mechanical calculations have revealed that the pyrrolo[1,2-a]pyrimidine core exhibits aromaticity and conjugation patterns that are critical for its stability and reactivity. The presence of the dioxaborolane group has been shown to influence these properties by introducing additional electron-withdrawing effects or steric bulk depending on its orientation within the molecule.

In terms of applications, this compound has shown promise in several areas. In materials science, it has been explored as a potential building block for constructing advanced materials with tailored electronic properties. For example, researchers have investigated its use in designing organic semiconductors for applications in flexible electronics and optoelectronic devices. The unique combination of aromaticity and boron functionality makes it an attractive candidate for such purposes.

In addition to its materials science applications, this compound has also been studied for its potential role in drug discovery. The pyrrolo[1,2-a]pyrimidine framework is known to exhibit bioactivity across various biological systems. Recent studies have demonstrated that derivatives of this compound can modulate key cellular pathways involved in inflammation and oxidative stress. The incorporation of the dioxaborolane group has been found to enhance bioavailability and pharmacokinetic properties without compromising activity.

From an environmental standpoint, there is growing interest in understanding how such compounds interact with biological systems under various conditions. Researchers have conducted extensive toxicity studies to assess their safety profiles for potential therapeutic use. These studies have revealed that while certain derivatives exhibit potent biological activity at low concentrations they generally show minimal toxicity to non-target cells.

Looking ahead future research directions are likely to focus on further optimizing this compound's properties through strategic modifications of its substituents or by exploring novel synthetic pathways that enable greater control over its structure-function relationships. Collaborative efforts between chemists biologists and material scientists will be essential for unlocking its full potential across diverse application areas.

• 321724-19-0(5-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine)
• 754214-56-7(5-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine)
• 1204742-76-6(6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-YL)imidazo[1,2-A]pyridine)
• 1052686-67-5(2-methyl-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine)
• 1353387-21-9(8-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridine)
• 402960-38-7(5-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine)
• 945256-29-1(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine)
• 1036379-05-1(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,8-Naphthyridine)
• 2018362-18-8(6-(tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyrimidine)
• 1476076-45-5(4,6-dideuterio-2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine)